Craig R Stapleton insider trades: Avadel Pharmaceuticals (AVDL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Craig reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 27, 2017 | AVDL | ↓ Sell | 254,265 | $9.35 | $2.4M | Direct | Nov 29, 2017 (2d) |
| Sep 12, 2017 | AVDL | ↑ Buy | 20,000 | $9.52 | $190K | By Spouse | Sep 14, 2017 (2d) |
| May 22, 2017 | AVDL | ↑ Buy | 31,013 | $9.85 | $305K | By Spouse | May 22, 2017 (0d) |
| Nov 29, 2016 | FLML | ↑ Buy | 20,000 | $10.79 | $216K | By Spouse | Nov 30, 2016 (1d) |
| Sep 1, 2016 | ANF | ↑ Buy | 10,000 | $17.65 | $177K | Direct | Sep 6, 2016 (5d) |
| Sep 1, 2016 | FLML | ↑ Buy | 10,000 | $13.52 | $135K | Direct | Sep 6, 2016 (5d) |
| Aug 26, 2016 | FLML | ↑ Buy | 20,000 | $13.76 | $275K | By Spouse | Aug 29, 2016 (3d) |
| May 16, 2016 | FLML | ↑ Buy | 27,228 | $9.21 | $251K | Direct | May 16, 2016 (0d) |
| Mar 14, 2016 | FLML | ↑ Buy | 100,000 | $10.39 | $1.0M | Direct | Mar 16, 2016 (2d) |
| Jun 22, 2015 | ANF | ↑ Buy | 10,000 | $22.42 | $224K | Direct | Jun 29, 2015 (7d) |
| May 30, 2014 | ANF | ↑ Buy | 10,000 | $37.30 | $373K | Direct | Jun 2, 2014 (3d) |
| Jun 25, 2013 | ANF | ↑ Buy | 10,000 | $44.01 | $440K | Direct | Jul 1, 2013 (6d) |
| May 22, 2012 | ANF | ↑ Buy | 10,000 | $35.43 | $354K | Direct | May 23, 2012 (1d) |
| Sep 20, 2011 | ANF | ↓ Sell | 7,398 | $69.70 | $516K | Direct | Sep 22, 2011 (2d) |
| Aug 20, 2010 | ANF | ↑ Buy | 7,398 | $35.51 | $263K | Direct | Aug 24, 2010 (4d) |
| Feb 20, 2009 | SWHI | ↑ Buy | 5,000 | $7.00 | $35K | Direct | Feb 24, 2009 (4d) |
| Dec 15, 2008 | SWHI | ↑ Buy | 27,500 | $7.50 | $206K | Direct | Dec 17, 2008 (2d) |
| Nov 14, 2006 | SWHI | ↓ Sell | 75,100 | $11.50 | $864K | Direct | Nov 16, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AVDL insiders
Open-market trades in the last 12 months
About Craig R Stapleton's insider trades
Craig R Stapleton is a director at Avadel Pharmaceuticals (AVDL). Since Nov 14, 2006, Craig has reported 15 open-market purchases worth $4.5M and 3 sales worth $3.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), option exercises (10 filings), other transactions (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.